New Delhi: Pharmaceutical giant AstraZeneca has announced the global withdrawal of its Covid-19 vaccine. The company cited a surplus of newer vaccine options as the primary reason behind this decision.
AstraZeneca has voluntarily withdrawn the “marketing authorization” for the vaccine within the European Union, with similar applications expected to be made in other countries where the vaccine was previously approved.
This decision comes amidst ongoing legal battles faced by AstraZeneca, including allegations linking its vaccine, developed in collaboration with the University of Oxford, to fatalities and severe injuries, notably Thrombosis with Thrombocytopenia Syndrome (TTS).
However, the company has clarified that the withdrawal is not directly linked to ongoing court cases or its admission of TTS side effects. Instead, AstraZeneca attributed the decision to commercial reasons and a decline in demand for the vaccine.
“As multiple variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines,” stated AstraZeneca in a released statement.
New Delhi: The Centre has decided to remove the existing 12-minute-per-hour cap on television advertisements,…
Bhubaneswar: For Jhunulata Naik of Cuttack, survival once meant cleaning toilets at a nursing home…
Bhubaneswar: The Odisha government has stepped up efforts to accelerate industrial infrastructure projects across the…
Bhubaneswar: With young people increasingly exposed to online fraud, cyber blackmail and digital exploitation, Odisha…
Bhubaneswar: Odisha is set to tighten its solid waste management framework with a renewed focus…
Bhubaneswar: Odisha has launched a statewide digital skill enhancement programme for officials of Primary Agricultural…
